United States · Series B startup
2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$93Mraised across 2 rounds since 2005, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Highland Capital Partners
Morgan Stanley Investment Management
Investor AB
Thomas, McNerney & PartnersReported by solsticeneuro.com
Morgan Stanley Investment ManagementInvestor ABThomas, McNerney & PartnersFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Solstice Neurosciences's investors include Morgan Stanley Investment Management, Investor AB, Oxford Bioscience Partners, Thomas, McNerney & Partners and Highland Capital Partners.
Solstice Neurosciences has raised $93M across 2 rounds since 2005.
Solstice Neurosciences's most recent round was a Series B of $85M in Nov 2006.
Its most recent round, $85M in Nov 2006, is also its largest on record.
Solstice Neurosciences's first round on record, in Jul 2005, was backed by Morgan Stanley Investment Management, Investor AB and Oxford Bioscience Partners and 1 others.
Solstice Neurosciences's latest named round is a Series B, in Nov 2006.
Solstice Neurosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·